Rajaram Narayanan to lead SeQuent through next phase of consolidation and growth
SeQuent, animal healthcare company has announced that its board of directors appointed Rajaram Narayanan as Managing Director and Chief Executive Officer, effective 11 April 2022.
Narayanan, who has served in senior leadership roles across the pharmaceutical, consumer goods and services industries, succeeds Manish Gupta who will be stepping down effective 10 April 2022 after serving as MD and CEO of SeQuent for the past eight years. He joins from Sanofi India, where he was the Managing Director and Country Chair for India. Before this, he was Chief Marketing Officer at Airtel, India’s leading telecommunications company. He started his career at Hindustan Unilever, where he held various leadership roles in India and other Asian markets for over 18 years, building and managing many iconic consumer brands.
On his appointment as Rajaram Narayanan, MD & CEO, SeQuent said, “I am honoured to join SeQuent, particularly at a time when the global animal healthcare industry is growing at a significant pace due to increased demand for quality livestock and food safety, and a rise in adoption of companion animals. As one of the leading animal healthcare companies globally, SeQuent is uniquely positioned to seize these market opportunities, and I am excited to lead the company through its next phase of development.”